Endogenous middle molecules (MM), which accumulate in uremia are more efficiently removed and better controlled by CAPD than by other forms of dialysis treatment. The generation rate of MM's in CAPD patients is closely related to protein intake and/or breakdown.
Get full access to this article
View all access options for this article.
References
1.
ScribnerB.H.Discussion.Trans Am Soc Artif Intern Organs1965; 11: 29.
2.
JebsenR.H., TenckhoffH., HoultJ.C.Natural history of uremic polyneuropathy and the effects of dialysis.New Engl J Med1967; 277: 327.
3.
BabbA.L., PopovichR.P., ChristopherT.O., ScribnerB.H.The genesis of the square meter-hour hypothesis.Trans Am Soc Artif Intern Organs1971; 17: 81.
4.
BabbA.L., FarrellP.C., UvelliD.A., ScribnerB.H.Hemodialyzer evaluation by examination of solute molecular spectra.Trans Am Soc Artif Intern Organs1972; 19: 98.
5.
BergströmJ., FurstP., ZimmermanL.Uremic middle molecules exist and are biologically active.Clin Nephrol1979; 11: 229.
6.
ZirnrnermanL., BaldestenA., BergströmJ., Fui'stP.Isotachophoretic separatino of middle molecule peptides in uremic body fluids.Clin Nephrol1980; 14: 183.
7.
SaitoA., KanazawaI., ChungT.O., MaedaK.Analytical study for separation of middle molecules.Artif Organs1980; 4: 13.
8.
AsabaH., AlvestrandA., BergströmJ.Uremic middle molecules in non-dialyzed azotemic patients: Relation to symptoms and clinical biochemistries.Clin Nephrol1982; 17: 90.
9.
AsabaH., BergstromJ., FirstP.Plasma middle molecules in asymptomatic and .‘sick.’ uremic patients.Artif Organs1980; 4: 137.
10.
ManN.K., CueilleO., ZingraffJ., BoudetJ.Uremic neurotoxin in the middle molecular weight range.Artif Organs1980; 4: 116.
11.
PopovichR.P., MoncriefJ.W.Kinetic modeling of peritoneal transport.Contr Nephrol1979; 17: 59.
12.
FtirstP., ZimmermanL., BergströmJ.Determination of endogenous middle molecules in normal and uremic body fluids.Clin Nephrol1976; 5: 178.
13.
BergströmJ., AsabaH., FirstP., LindholmB.Middle molecules in chronic uremic patients treated with peritoneal dialsyis. In: OahlO.M., KesselM., NolphK.D., eds. Advances in peritoneal dialysis.Amsterdam: Excerpta Medica, 1982: 47–53.
AsabaH., BergstromJ., FirstP.Plasma middle moleules in asymptomatic and “sick.’ uremic patients (abstract). Symposium of present status and future orientation of research on the importance of middle molecules in uremia and other diseases. A vignon, France, 1980.
16.
BergströmJ., AsabaH., FirstP.Middle molecules in uremia. In: OiovanettiS., BonominiV.D., AmicoO.D., eds. Proceedings of the sixth international congress of nephrology.Basel: S. Karger. 1976: 600.
17.
AsabaH., BergströmJ., FirstP.Accumulation and excretion of middle molecules.Proc EDTA1976; 13: 481.
18.
ChapmanO.V., FarrellP.C.Size. composition and dialytic removal of uremic middle molecules (UMMs) (abstract). Symposium of present status and future orientation of research on the importance of middle molecules in uremia and other diseases, Avignon, France, 1980.
